Ethylene Glycol-Linked Amino Acid Diester Prodrugs of Oleanolic Acid for PepT1-Mediated Transport: Synthesis, Intestinal Permeability and Pharmacokinetics

被引:47
作者
Cao, Feng [2 ]
Jia, Jinghao [1 ]
Yin, Zhi [2 ]
Gao, Yahan [2 ]
Sha, Lei [1 ]
Lai, Yisheng [1 ]
Ping, Qineng [2 ]
Zhang, Yihua [1 ]
机构
[1] China Pharmaceut Univ, Ctr Drug Discovery, State Key Lab Nat Med, Sch Pharm, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Dept Pharmaceut, State Key Lab Nat Med, Sch Pharm, Nanjing 210009, Peoples R China
基金
高等学校博士学科点专项科研基金; 中国国家自然科学基金;
关键词
oleanolic acid; peptide transporter 1; ester prodrug; in situ single-pass intestinal perfusion; pharmacokinetics; bioavailability; IN-VITRO EVALUATION; PEPTIDE TRANSPORTERS; DIPEPTIDE PRODRUGS; RECEPTOR AGONIST; ESTER PRODRUGS; ABSORPTION; PERFUSION; DELIVERY; DESIGN; GABAPENTIN;
D O I
10.1021/mp200447r
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The purposes of this study were to expand the structure of parent drugs selected for peptide transporter 1 (PepT1)-targeted ester prodrug design and to improve oral bioavailability of oleanolic acid (OA), a Biopharmaceutics Classification System (BCS) class IV drug. Through an ethoxy linker the carboxylic acid group of OA was conjugated with the carboxylic acid group of different amino acid promoieties to form six diester prodrugs. The effective permeability (P-eff) of prodrugs was screened by in situ rat single-pass intestinal perfusion (SPIP) model in two buffers with different pH (6.0 and 7.4) as PepT1 employs a proton-gradient as the driving force. Compared to OA, 2.5-fold, 2.3-fold, 2.2-fold, 2.1-fold, and 1.9-fold enhancement of P-eff in buffer with pH 6.0 was observed for L-Phe ester (5c), L-Val ester (5a), L-Lys ester (5e), D-Phe ester (5d), and D-Val ester (5b), respectively. Furthermore, P-eff of 5a, 5c, 5d and Se in pH 6.0 was significantly higher than that in pH 7.4 (p < 0.01), respectively. These results showed that the H+ concentration of perfusion solution had great effect on the transport of the prodrugs across intestinal membrane. For the further evaluation of affinity to PepT1, inhibition studies were performed by coperfusing 0.1 mM prodrug with 50 mM glycyl-sarcosine (Gly-Sar, a typical substrate of PepT1). It turned out that the P-eff of 5a, 5b, 5c and L-Tyr ester (6f) significantly reduced in the presence of Gly-Sar (1.7-fold, 2.2-fold, 1.9-fold, and 1.4-fold, respectively). We supposed that it may be attributed to PepT1 mediated transport of these prodrugs. 5a and 6f were selected as the optimal target prodrugs for oral absorption in vivo. Following intragastric administration of 300 mg/kg (calculated as OA) 5a, 6f and OA in three groups of rats, compared with group OA, C-max for the group of 5a and 6f was enhanced by 1.56-fold and 1.54-fold, respectively. F-app of group 5a and 6f was 2.21- and 2.04-fold increased, respectively, indicating that 5a and 6f had better oral absorption than OA. The combined results also suggest that diester prodrugs which conjugated two carboxylic acid groups of proper amino acid promoieties and parent drug through a linker can be used for PepT1-targeted prodrug design. With this strategy, oral bioavailability of OA in rats could be improved significantly.
引用
收藏
页码:2127 / 2135
页数:9
相关论文
共 49 条
[1]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]
Bailey PD, 2000, ANGEW CHEM INT EDIT, V39, P506
[3]
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls [J].
Brandsch, Matthias .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (08) :887-905
[4]
Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect [J].
Chen, YJ ;
Liu, J ;
Yang, XL ;
Zhao, XL ;
Xu, HB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (02) :259-264
[5]
Enhanced analysis of triterpenes, flavonoids and phenolic compounds in Prunella vulgaris L. by capillary zone electrophoresis with the addition of running buffer modifiers [J].
Cheung, Hon-Yeung ;
Zhang, Qing-Feng .
JOURNAL OF CHROMATOGRAPHY A, 2008, 1213 (02) :231-238
[6]
Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat [J].
Cook, TJ ;
Shenoy, SS .
TOXICOLOGY, 2003, 184 (2-3) :125-133
[7]
XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug:: II.: Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys [J].
Cundy, KC ;
Annamalai, T ;
Bu, L ;
De Vera, J ;
Estrela, J ;
Luo, W ;
Shirsat, P ;
Torneros, A ;
Yao, FM ;
Zou, J ;
Barrett, RW ;
Gallop, MA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :324-333
[8]
The Intestinal Absorption of a Prodrug of the mGlu2/3 Receptor Agonist LY354740 is Mediated PEPT1: In Situ Rat Intestinal Perfusion Studies [J].
Eriksson, Andre H. ;
Varma, Manthena V. S. ;
Perkins, Everett J. ;
Zimmerman, Cheryl L. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (03) :1574-1581
[9]
Comparison between permeability coefficients in rat and human jejunum [J].
Fagerholm, U ;
Johansson, M ;
Lennernas, H .
PHARMACEUTICAL RESEARCH, 1996, 13 (09) :1336-1342
[10]
The in vitro transport of model thiodipeptide prodrugs designed to target the intestinal oligopeptide transporter, PepT1 [J].
Foley, David ;
Pieri, Myrtani ;
Pettecrew, Rachel ;
Price, Richard ;
Miles, Stephen ;
Lam, Ho Kam ;
Bailey, Patrick ;
Meredith, David .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2009, 7 (18) :3652-3656